题名 | Factors influencing macular atrophy growth rates in neovascular age-related macular degeneration treated with ranibizumab or aflibercept according to an observe-and-plan regimen | 链接 | https://www.ncbi.nlm.nih.gov/pubmed/?term=30166328 |
https://www.ncbi.nlm.nih.gov/pubmed/?term=30166328 |